Coverage
-
February 19, 2019
The U.S. Supreme Court dealt a final blow Tuesday to a landmark Maryland law aimed at stopping generic-drug makers from price gouging when it refused to review the Fourth Circuit's decision that the law is unconstitutional.
3 other articles on this case.
View all »